Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy

O Tomkins-Netzer, R Niederer, J Greenwood… - Progress in Retinal and …, 2024 - Elsevier
Blood-retinal barrier (BRB) disruption is a common accompaniment of intermediate,
posterior and panuveitis causing leakage into the retina and macular oedema resulting in …

Te hauora karu o te iwi Māori: A comprehensive review of Māori eye health in Aotearoa/New Zealand

M Rapata, W Cunningham, M Harwood… - Clinical & …, 2023 - Wiley Online Library
This article provides a summary of available data on Māori ocular health, highlighting
significant disparities between Māori and non‐Māori populations. Māori are more likely to …

Etanercept-associated episcleritis: a pediatric case report of a paradoxical adverse reaction and review of the literature

B Küçükali, D Gezgin Yıldırım, P Esmeray Şenol… - Clinical …, 2024 - Springer
Scleritis is an inflammation of the episcleral and scleral tissues, characterized by injection in
both superficial and deep episcleral vessels. When only episcleral tissue is involved, it is …

Uveitisinduktion durch immunonkologische Therapien, speziell Checkpoint-Inhibitoren

JG Garweg - Klinische Monatsblätter für Augenheilkunde, 2022 - thieme-connect.com
Hintergrund Immun-Checkpoint-und BRAF-/MEK-Inhibitoren (ICI) haben eine zentrale
Stellung in der Krebstherapie eingenommen, da sie eine erhebliche Lebensverlängerung …

Posterior scleritis following a single infusion of zoledronate for osteoporosis: A case report and literature review

D Ma, C Xiao, D Zhao, G Li, W Cheng… - Clinical Case …, 2024 - Wiley Online Library
Key Clinical Message The most frequently reported adverse reaction to zoledronic acid is an
acute phase reaction resembling influenza. While rarer adverse events such as …

[PDF][PDF] Zoledronate-induced anterior uveitis, scleritis and optic neuritis: a case report

LE Wolpert, AR Watts - NZ Med J, 2021 - nzmj.org.nz
Discussion Orbital inflammation is an uncommon side effect of zoledronate infusion. The
incidence of zoledronate-associated AAU has been reported at around 1.1%. 3 To our …

Uveitis, a rare but important complication of adjuvant zoledronic acid for early-stage breast cancer

G Chacko, S Kota, S Kumar, N Ohri, C Omene… - Anti-Cancer …, 2023 - journals.lww.com
Bisphosphonates such as zoledronic acid are an important part of adjuvant therapy to
reduce the risk of recurrence in early-stage breast cancer. Uveitis remains one of the lesser …

Response To:“Bisphosphonates Related Ocular Side Effects: A Case Series and Review of Literature”

P Samalia, J Sims, R Niederer - Ocular Immunology and …, 2022 - Taylor & Francis
Dear Editor We have read the article entitled “Bisphosphonates Related Ocular Side Effects:
A Case Series and Review of Literature” by Gendelman et al., 2021, Doi: 10.1080 …

Uveitis, a Rare but Important Complication of adjuvant Zoledronic acid in breast cancer

G Chacko, S Kota, S Kumar, N Ohri, C Omene… - 2022 - researchsquare.com
Adjuvant therapy has become a crucial part in reducing risk of recurrence after surgical
intervention. Bisphosphonates such as zoledronic acid have been used as part of adjuvant …

Zoledronic acid-induced posterior scleritis associated with inflammatory orbitopathy

G Larid, C Inglard, J Mahe, F Roy-Peaud, F Debiais - Joint Bone Spine, 2022 - Elsevier
T2-STIR-weighted MRI (axial (A) and coronal (B)) showed inflammation in whole left orbitary
region and Optical Coherence Tomography demonstrated choroidal folds (C) in a 77-year …